Tag: ASCEMBL

Deep responses with asciminib in CML-CP  

Presented By
Prof. Timothy Hughes, University of Adelaide, Australia
Trial
Phase 3, ASCEMBL
Conference
EHA 2023
Type
Peer-reviewed article

2 August 2023 16:41

First-in-class STAMP inhibitor versus bosutinib in resistant or intolerant CML

Presented By
Dr Andreas Hochhaus, Universitätsklinikum Jena, Germany
Trial
Phase 3, ASCEMBL
Conference
ASH 2020
Type
Peer-reviewed article

18 February 2021 08:58
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com